Inspra (Eplerenone) – Patient Information for the UK

Inspra is the brand name of eplerenone, a medicine that belongs to the group known as mineralocorticoid receptor antagonists (also called “MRAs”). It helps protect the heart and can also help reduce strain on blood vessels by blocking the effects of hormones that retain salt and water.

This page explains what Inspra does, how it works in the body, how it is typically taken, important interactions and safety points, and practical tips to help you use it effectively. It is written for people in the United Kingdom.

Basic product information

• Medicine: Inspra
• Active ingredient: Eplerenone
• Medicinal group: Mineralocorticoid receptor antagonist (MRA)
• Common strengths: Tablets (often 25 mg and 50 mg, depending on local availability)
• How it’s taken: Oral tablets
• Who it’s for: Adults who meet specific clinical criteria (most commonly certain heart conditions)

What Inspra does (indications)

In the UK, eplerenone is used to treat certain heart-related conditions, most commonly:

• Heart failure after a heart attack (post-myocardial infarction left ventricular dysfunction): Eplerenone can be used in people who have symptoms or signs of reduced heart pumping function after a heart attack.
• Heart failure with reduced pumping function: It may be used in selected patients as part of broader heart-failure management, usually where appropriate based on kidney function and blood potassium levels.

The exact use and whether you qualify depends on factors such as your kidney function, potassium level, and your overall heart treatment plan.

How Inspra works (mechanism of action)

Eplerenone blocks mineralocorticoid receptors. These receptors respond to hormones such as aldosterone. Aldosterone can contribute to:

• Salt and water retention (which increases fluid load)
• Increased blood pressure
• Changes in the heart and blood vessels (remodelling that can worsen heart function)
• Potassium loss in the body

By blocking aldosterone’s effects, Inspra helps: reduce fluid retention and support the heart, while also tending to raise potassium levels slightly. This is why potassium monitoring is important.

Pharmacokinetics (how the body handles Inspra)

“Pharmacokinetics” describes how the body absorbs, distributes, metabolises, and removes a medicine.

• Absorption: Eplerenone is absorbed after oral dosing. Taking it at consistent times can help maintain steady exposure.
• Peak levels (Cmax): The medicine reaches its highest blood concentration typically within a few hours after taking a dose.
• Metabolism: Eplerenone is mainly metabolised in the liver, involving the CYP3A4 enzyme.
• Elimination: It is removed from the body via kidney and other pathways. Kidney function can affect overall exposure.
• Half-life: Eplerenone has a duration that supports once-daily dosing in many regimens.

Because eplerenone can affect potassium and because kidney function influences drug exposure, your clinician usually checks: blood potassium and kidney function before starting and during treatment.

Typical use and timing

Inspra is usually taken once daily. In practice, timing can depend on your specific plan, your other heart medications, and how your blood results respond.

• Best approach: Take your tablet at the same time each day.
• If you miss a dose: Take it when you remember on the same day. If it is close to the time of your next dose, skip the missed dose and continue as normal. Do not double up.
• Monitoring: You may need blood tests soon after starting or adjusting the dose, and again periodically.

Dosing (general guidance)

Dosing is individual. The safest and most effective dose depends on your potassium level, kidney function, and your overall treatment.

Common starting and adjustment principles in adults include:

• Starting dose: Often begins at a low dose (commonly 25 mg once daily in many regimens) in people at risk of higher potassium.
• Adjustment: The dose may be increased after blood tests if potassium levels remain safe and kidneys can handle the therapy.
• Maximum dose: Depends on clinical factors and local guidance.

Important: Always follow the instructions given with your medicine. If you are unsure about your dose or schedule, check with a healthcare professional or refer to the patient information leaflet that comes with your product.

Food interactions and taking Inspra with meals

Food may influence absorption for eplerenone. Many people are advised to take it consistently with regard to meals. In day-to-day terms:

• Consistency helps: If your regimen is “with or without food,” try to follow that same pattern daily.
• Reduced GI upset: Some people find it easier to take the tablet with food if they feel mild stomach discomfort.

If you have been instructed to take Inspra in a particular way relative to meals, follow your clinician’s advice.

Alcohol and medicine interactions

Alcohol

Moderate alcohol intake is not usually a direct interaction with eplerenone. However, alcohol may:

• Worsen dehydration, which can affect kidney function
• Increase risk of dizziness or low blood pressure in some people, especially those on multiple cardiovascular medicines

If you drink alcohol, it’s sensible to keep it moderate and avoid binge drinking. If you experience dizziness or feel unwell, speak to your healthcare team.

Other medicine interactions (important)

Because eplerenone can raise potassium, and because it is metabolised by liver enzymes (notably CYP3A4), interactions can be clinically significant.

• Potassium supplements and salt substitutes: Avoid potassium-containing salt substitutes unless specifically advised. These can increase potassium dangerously.
• Other medicines that raise potassium: Examples include:
  • ACE inhibitors (e.g., ramipril, enalapril)
  • Angiotensin II receptor blockers (ARBs) (e.g., losartan, valsartan)
  • Other MRAs (e.g., spironolactone)
  • Some diuretics or other medicines depending on your regimen
  Combination may be appropriate in selected patients, but requires careful monitoring.
• Kidney-affecting medicines: Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen or naproxen can affect kidney function, which may raise potassium risk in combination with eplerenone.
• CYP3A4 inhibitors (may increase eplerenone exposure): Some antibiotics and antifungal medicines, certain antivirals, and other drugs can increase eplerenone levels, potentially raising the risk of high potassium. Examples may include strong CYP3A4 inhibitors (exact list depends on your medicines).
• CYP3A4 inducers (may reduce eplerenone effectiveness): Some medicines can decrease eplerenone exposure. If you start a new medicine, ask whether it may affect eplerenone.

Keep an up-to-date list of all medicines and supplements you take (including herbal products) and review it with a clinician or pharmacist.

Safety profile and key risks

Most people tolerate Inspra well, but it has important safety considerations—mainly related to potassium levels and kidney function.

Most important risks

• Hyperkalaemia (high potassium): This can be serious and may cause:
  • Muscle weakness
  • Tingling
  • Nausea
  • Slow or irregular heartbeat (palpitations)
• Kidney function changes: Because your kidneys help regulate potassium and clear medicines, reduced kidney function can increase risk.
• Low blood pressure (hypotension): Especially if you are also on blood pressure medicines or have dehydration.

Less common side effects

These may occur in some people:

• Dizziness
• Fatigue
• Headache
• Stomach upset

Seek urgent medical help if you notice

• Severe weakness or sudden unusual muscle symptoms
• Fainting or severe dizziness
• Chest pain, severe shortness of breath, or pronounced irregular heartbeat

Practical use tips for everyday life

• Attend blood tests: Your clinician will check potassium and kidney function before starting and at intervals after starting or dose changes.
• Be cautious with “low salt” products: Many salt substitutes contain potassium. Unless your healthcare team specifically approves them, avoid them.
• Stay hydrated appropriately: In hot weather or if you are ill with vomiting/diarrhoea, fluid balance can change quickly. If you are unwell, ask your clinician for advice on whether to pause medicines temporarily.
• Medication review: Each time you see a healthcare professional, review your full list of medicines, including OTC pain relief and supplements.
• Consistent schedule: Take your dose at the same time daily. If you struggle with routines, consider linking it to a daily habit (e.g., after breakfast).

What to do if you miss a dose

If you forget a dose:

• Take it as soon as you remember on the same day.
• If it is close to the time of your next dose, skip the missed dose.
• Do not take two doses together to make up for the missed one.

If you miss several doses or are unsure what to do, contact a healthcare professional for advice.

Alternative options (if Inspra isn’t suitable)

Alternatives depend on why you are taking eplerenone and your overall medical history. In UK practice, options may include other medicines used for similar heart conditions, such as:

• Other MRAs: Spironolactone is another mineralocorticoid receptor antagonist often used in heart failure. Some people prefer one over the other depending on side effects and tolerability.
• Other heart failure medicines: Depending on your diagnosis, clinicians may use combinations such as beta-blockers, ACE inhibitors, ARBs, or other guideline-directed therapies.
• Diuretics for fluid control: Some medicines help with fluid balance, though they work differently from eplerenone.

The “best alternative” for you will depend on kidney function, potassium levels, blood pressure, and the treatments you already take. Always discuss changes with a healthcare professional.

UK market and legal context (high-level)

Medicines like Inspra are regulated in the UK and used under healthcare supervision. In the UK, medicines are categorised according to whether they require prescription-only arrangements or can be supplied via other routes. The exact supply pathway for eplerenone products can vary by product strength, local pharmacy policies, and clinical requirements.

In general, for safety reasons—particularly the need for monitoring potassium and kidney function—eplerenone therapy should be initiated and supervised by appropriate healthcare professionals.

Clinical guidance: Treatment decisions in the UK are commonly aligned with evidence-based heart failure and post-heart-attack management guidance, including periodic updates from relevant clinical bodies and healthcare organisations. You may see changes over time in how MRAs are recommended for specific patient groups, including emphasis on appropriate monitoring.

Recent guidance and monitoring (what to expect)

While specific wording of “recent guidance” can evolve, the consistent UK-wide safety focus for eplerenone remains:

• Careful patient selection: Suitable baseline kidney function and potassium levels.
• Regular blood tests: Especially after starting or increasing the dose.
• Interaction awareness: Extra caution when adding medicines that affect potassium, kidneys, or liver metabolism.

If you are prescribed Inspra, ask your healthcare professional for the schedule of blood tests and what symptoms to watch for.

Delivery and availability (online pharmacy)

Availability of Inspra can vary depending on stock levels, tablet strength, and manufacturer supply. When ordering through an online pharmacy, typical delivery expectations in the UK may include:

• Standard delivery: Commonly a few working days (varies by provider and location).
• Tracking: Many pharmacies offer order tracking or confirmation emails.
• Packaging: Medicines are usually supplied in tamper-evident packaging with patient information included.

Before ordering, check:

• The tablet strength you need
• Your delivery address and availability for receipt
• Whether you require any cool storage (most tablets do not, but always follow the package instructions)

If a product is out of stock, customer support can usually advise on expected restock dates or suitable equivalents.

Summary table (quick reference)

FAQ: Frequently asked questions

1) What is Inspra used for?

Inspra (eplerenone) is used for specific heart conditions, most commonly certain types of heart failure—often in people with reduced heart function after a heart attack. Use depends on your clinical profile, including potassium and kidney function.

2) How quickly will Inspra start working?

Some effects on fluid balance and hormone pathways may occur within days, but the overall benefits for heart failure are typically assessed over weeks to months. Your clinician will monitor how you are doing and may adjust the dose.

3) Why do I need blood tests?

Eplerenone can raise potassium levels and can affect kidney function. Blood tests help ensure potassium stays in a safe range and that your kidneys can safely handle treatment.

4) Can I take it with food?

Your dosing instructions may specify with or without food. Follow those instructions and keep your routine consistent from day to day. If you’re unsure, check the patient information leaflet or ask a pharmacist.

5) Can I use salt substitutes?

Many salt substitutes contain potassium. Because Inspra can increase potassium, you should generally avoid potassium-containing substitutes unless a healthcare professional explicitly tells you it is safe.

6) What medicines should I avoid with Inspra?

Interactions vary, but key categories include: potassium supplements, NSAIDs (e.g., ibuprofen) without medical advice, and certain drugs that increase potassium or affect liver metabolism (CYP3A4). Always check with your pharmacist before starting new medicines.

7) Is it safe to drink alcohol?

Moderate alcohol intake is not usually a direct interaction, but alcohol can contribute to dehydration and may worsen dizziness or low blood pressure. If you are unsure, ask your clinician for personalised advice—especially if you have kidney problems or feel light-headed.

8) What should I do if I feel unwell while taking Inspra?

If you have vomiting or diarrhoea, severe dizziness, fainting, or symptoms that could suggest abnormal potassium (such as marked weakness or palpitations), contact your healthcare team promptly. They may advise temporary changes during illness.

9) Are there alternatives to Inspra?

Depending on your diagnosis and tolerance, alternatives may include another MRA (such as spironolactone) or other medicines for heart failure. The right option depends on your potassium level, kidney function, and the rest of your treatment.

10) Where can I get more information?

Refer to the patient information leaflet supplied with your medicine and discuss any questions with a pharmacist or healthcare professional. If you have symptoms or concerns, seek medical advice.

Important: This information is intended as a general patient guide. Individual dosing and safety checks are essential for eplerenone therapy, particularly regarding potassium and kidney function. Always follow your healthcare professional’s instructions and the medicine’s patient leaflet.